undamentalytics Newsletter

Outset Medical vs Rxsight

Outset Medical and Rxsight are similar in size: $119m and $134m of revenue in their latest fiscal years. Outset Medical grew faster (5.1% against -3.9%). Rxsight kept more of each dollar of sales as profit: a net margin of -29.0% against -68.3%. Rxsight carries less debt relative to equity (0.0% against 75.8%).

Latest fiscal yearOutset MedicalOM, 2025RxsightRXST, 2025
Revenue $119m $134m
Revenue growth 5.1% -3.9%
Net income −$81.7m −$38.9m
Operating margin -55.8% -35.8%
Net margin -68.3% -29.0%
Return on equity -106.2% -14.0%
Free cash flow −$47.1m −$19.3m
Cash $35.0m $19.9m
Total debt $96.2m $0
Debt to equity 75.8% 0.0%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 254 461
Market value $76.3m $192m
Price vs our value range — —
Moat score 12 (Weak) 27 (Weak)
Insider trades, 12 months 2 buys, 23 sales 0 buys, 4 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.